---
annotations:
- id: CL:0000903
  parent: native cell
  type: Cell Type Ontology
  value: natural T-regulatory cell
- id: DOID:162
  parent: disease of cellular proliferation
  type: Disease Ontology
  value: cancer
- id: CL:0000145
  parent: native cell
  type: Cell Type Ontology
  value: professional antigen presenting cell
- id: PW:0000023
  parent: regulatory pathway
  type: Pathway Ontology
  value: immune response pathway
- id: CL:0000623
  parent: native cell
  type: Cell Type Ontology
  value: natural killer cell
- id: CL:0000084
  parent: native cell
  type: Cell Type Ontology
  value: T cell
- id: PW:0000825
  parent: regulatory pathway
  type: Pathway Ontology
  value: antigen processing and presentation pathway
- id: CL:0001063
  type: Cell Type Ontology
  value: neoplastic cell
- id: CL:0000542
  parent: native cell
  type: Cell Type Ontology
  value: lymphocyte
- id: CL:0000235
  parent: native cell
  type: Cell Type Ontology
  value: macrophage
authors:
- Khanspers
- DeSl
- Eweitz
citedin:
- link: PMC9138293
  title: 'An NF-κB- and Therapy-Related Regulatory Network in Glioma: A Potential
    Mechanism of Action for Natural Antiglioma Agents (2022)'
- link: PMC8751594
  title: DNA methylation of ARHGAP30 is negatively associated with ARHGAP30 expression
    in lung adenocarcinoma, which reduces tumor immunity and is detrimental to patient
    survival (2021)
communities:
- CPTAC
- ExRNA
description: The interplay between immune cells and microRNAs in the tumor microenvironment
  (TME). MRX34 and MRG‐106 (cobomarsen) are miRNA therapeutic agents. Adapted from
  figure 1 in [Cortez et al](https://www.ncbi.nlm.nih.gov/pubmed/30578699).
last-edited: 2025-03-03
ndex: e67a05e2-8b6b-11eb-9e72-0ac135e8bacf
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP4559
- /instance/WP4559
- /instance/WP4559_r137119
revision: r137119
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP4559.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: The interplay between immune cells and microRNAs in the tumor microenvironment
    (TME). MRX34 and MRG‐106 (cobomarsen) are miRNA therapeutic agents. Adapted from
    figure 1 in [Cortez et al](https://www.ncbi.nlm.nih.gov/pubmed/30578699).
  keywords:
  - CCL2
  - CCL5
  - CD274
  - CD80
  - CD86
  - CTLA4
  - CXCL10
  - IL2RA
  - IL2RB
  - IL2RG
  - IL4
  - IL4R
  - IRAK4
  - LPS
  - MIR138-1
  - MIR138-2
  - MIR146A
  - MIR200A
  - MIR200B
  - MIR200C
  - MIR203A
  - MIR203B
  - MIR21
  - MIR210
  - MIR212
  - MIR214
  - MIR23A
  - MIR24-1
  - MIR24-2
  - MIR27A
  - MIR29A
  - MIR34A
  - MIRLET7D
  - NFKB1
  - NFKB2
  - PDCD1
  - PIAS3
  - SOCS1
  - STAT3
  - STAT6
  - TGFB1
  - TGFB2
  - TGFB3
  - TGFBR2
  - TLR4
  - TLR7
  - TLR8
  - TRA
  - TRAF6
  - TRB
  license: CC0
  name: Interactions between immune cells and microRNAs in tumor microenvironment
seo: CreativeWork
title: Interactions between immune cells and microRNAs in tumor microenvironment
wpid: WP4559
---